SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 5, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 2/10
Horizondays Processed11d 4h ago
Insider cluster: 2 insiders, $367K total
Actionable Insight • Neutral

The sales are too small to signal a change in fundamentals. Monitor next quarterly filing for any operational updates, as the CEO also sold shares on the same date.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$120.79
T+0 close · Nov 5, 2026 · via day close
Latest settled
−7.61%
T+5 · $111.60
Vs SPY
−10.20%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $120.79entry
  2. T+1 · 8d ago +12.05%α +9.68% · $135.34
  3. T+5 · 4d ago −7.61%α −10.20% · $111.60
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two TWST insiders, including the President and COO, sold shares in open-market transactions totaling $367K on November 3, 2026. The sales are small relative to the company's $9.3B market cap (0.004%) and are not under 10b5-1 plans, but the dollar amount is immaterial.

Key Financial Metrics

Direction
selling
Total Value
$367.0K
Insiders
2

Key Facts

  • President and COO Patrick John Finn sold 2,565 shares for $347K on Nov 3, 2026
  • Chief Accounting Officer Robert F. Werner sold 148 shares for $20K on Nov 3, 2026
  • Total open-market sales of $367K represent 0.004% of TWST's $9.3B market cap
  • Neither sale was executed under a 10b5-1 plan
  • CEO Emily M. Leproust also sold $619K on Nov 3 (not in the cluster data but noted in cross-filing context)

Financial Impact

Total insider sales of $367K, immaterial relative to $9.3B market cap

Risk Factors

  • Multiple executives selling on the same day could indicate coordinated portfolio rebalancing, but the amounts are trivial
  • No 10b5-1 plans were used, but the small size suggests routine liquidity rather than informed selling

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
74% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1793912761669

Track record

47 reports on TWST

Performance horizon

8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
  3. Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
  4. Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
  5. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
  6. Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  7. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  8. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
  9. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Viewing Entry $120.79 Now $111.60 −7.61% settles Dec 7
  10. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
Showing 10 of 47

US Market Status

Market Closed · Opens Wed (12h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026